Suite M-46
Philadelphia, PA 19107
(215) 503-0156
(215) 503-3433 fax
Scopus Feed for this author is currently unavailable.
Medical School
BA California State University, Biology - 1969
MS California State University, Biology
- 1970
PhD University of California, Los Angeles, Cell Biology
- 1974
Postdoctoral Training: Tulane University School of Medicine, Hematopharmacology Training Grant, 1974-1977
Qualifications
Strategic Management Program, The Wharton School at the University of Pennsylvania 1988
Program on Negotiation for Senior Executives: Harvard Law School, Tufts University and MIT 1996
Program in Fundamentals of Finance for Technical Executives, MIT Sloan School of Management 2004
Expertise and Research Interests
Strategic Operations Management
Health policy issues
Biological Weapons Convention Compliance Issues
Organizational dynamics
Laboratory facility planning and management
Strategic planning
Competitive Intelligence
Laboratory facility design and construction
Laboratory security
Space planning
Site management
Industrial Relevance
Recently retired from 28 year career at Merck Research Labs. Worked in CV Pharmacology, Computer Resources, Capital Planning and Finance, Facility Management, Investment Planning & Analysis, M&A, Clinical Liaison in Japan, Capital laboratory construction projects in Italy, Japan, Canada, UK and US. Developed two angiotensin converting enzyme inhibitors that went to market (Vasotec, Prinivil) and worked on other drug discovery programs in renal pharmacology and the CNS. Expertise in laboratory design, facility planning, vivarium design, space planning/management, start-up and decommissioning. Director for the Pennsylvania Drug Discovery Institute and the International Society for Pharmaceutical Engineering